Mater hospitals in Brisbane and Springfield are transitioning to external pathology providers, citing rising costs.
More than 400 positions will be affected at Mater Pathology in Brisbane and Springfield as services are outsourced to external providers, with the healthcare provider blaming rising costs and inadequate Medicare subsidies.
AI-generated summary
Mater has outsourced its pathology services to external providers due to rising costs and inadequate Medicare subsidies over the past decade.
More than 400 positions are expected to be affected at Mater Pathology in Brisbane and Springfield as the hospitals transition to an external pathology provider.
A spokesperson for the healthcare provider blamed rising costs for the decision.
More than 100 positions will be lost in the next two months, with most of the remaining positions ending in 2027.
Mater has outsourced its pathology services in a move that will affect more than 400 staff.
The announcement was made today, just a month before Christmas.
The healthcare provider has blamed rising costs, saying Medicare subsidies have not kept pace with increasing financial pressures over the past decade.
Mater says the transition to external pathology providers will affect more than 400 part-time, full-time and casual employees over the next 12 to 18 months.
More than 100 positions will be lost in the next two months, with most of the remaining positions ending in 2027.
Under the new model, pathology services at Mater's Brisbane and Springfield hospitals will be delivered through specialist providers, including Sullivan Nicolaides Pathology and Pathology Queensland.
The change will not affect Mater hospitals in Townsville, Mackay, Rockhampton, Bundaberg or the Gold Coast, which already rely on external pathology service providers.
A Mater spokesperson said the decision would have "no impact on the high-quality care Mater patients receive".
"The pathology model Mater is adopting is used by private hospital operators across Australia and will allow more resources to be directed to the clinical care of our patients.
"We are deeply grateful to our Mater Pathology people," the spokesperson said.
"This decision is not a reflection on their capability, professionalism or commitment."
AI outlook — possibilities, not facts
More than 100 positions will be lost in the next two months.
Very likely · Within months
Remaining positions will end by 2027.
Very likely · Within months

Australian cattle farmer Greg Smith, diagnosed with Parkinson's disease, is among critics questioning the federal government's decision to permit continued use of the herbicide paraquat despite bans in over 70 countries and suspected health risks.
Dementia remained Australia's leading cause of death in 2025, accounting for one in 10 fatalities, according to the Australian Bureau of Statistics. Meanwhile, overall mortality rates returned to pre-pandemic levels.
Royal Darwin Hospital apologised to a dozen pregnant patients whose confidential medical data was shared on Instagram by an overseas-trained medical observer to 28,000 followers.
An Australian-led phase 3 trial shows a personalised mRNA cancer vaccine combined with immunotherapy reduces melanoma recurrence risk by 42 per cent.
A new AIHW report reveals a 15-fold increase in hospitalisations for teenage boys aged 12 to 15 following e-scooter falls between 2019/20 and 2024/25, highlighting growing safety concerns amid rising e-mobility use.
A new Flinders University report reveals Australian women with postpartum psychosis seek help an average of seven times before receiving care, with symptoms often dismissed as normal new motherhood.